These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8031024)

  • 1. Tetracycline analogs whose primary target is not the bacterial ribosome.
    Chopra I
    Antimicrob Agents Chemother; 1994 Apr; 38(4):637-40. PubMed ID: 8031024
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular basis of tetracycline action: identification of analogs whose primary target is not the bacterial ribosome.
    Rasmussen B; Noller HF; Daubresse G; Oliva B; Misulovin Z; Rothstein DM; Ellestad GA; Gluzman Y; Tally FP; Chopra I
    Antimicrob Agents Chemother; 1991 Nov; 35(11):2306-11. PubMed ID: 1725100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Tetracyclines: progress of fundamental research].
    Egorov AM; Sazykin IuO
    Antibiot Khimioter; 2004; 49(8-9):4-7. PubMed ID: 15727138
    [No Abstract]   [Full Text] [Related]  

  • 4. Tetracyclines: antibiotic action, uptake, and resistance mechanisms.
    Schnappinger D; Hillen W
    Arch Microbiol; 1996 Jun; 165(6):359-69. PubMed ID: 8661929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The bacterial ribosome, a promising focus for structure-based drug design.
    Knowles DJ; Foloppe N; Matassova NB; Murchie AI
    Curr Opin Pharmacol; 2002 Oct; 2(5):501-6. PubMed ID: 12324250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of protein synthesis occurring on tetracycline-resistant, TetM-protected ribosomes by a novel class of tetracyclines, the glycylcyclines.
    Rasmussen BA; Gluzman Y; Tally FP
    Antimicrob Agents Chemother; 1994 Jul; 38(7):1658-60. PubMed ID: 7526784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence that tetracycline analogs whose primary target is not the bacterial ribosome cause lysis of Escherichia coli.
    Oliva B; Gordon G; McNicholas P; Ellestad G; Chopra I
    Antimicrob Agents Chemother; 1992 May; 36(5):913-9. PubMed ID: 1510413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tetracyclines Modify Translation by Targeting Key Human rRNA Substructures.
    Mortison JD; Schenone M; Myers JA; Zhang Z; Chen L; Ciarlo C; Comer E; Natchiar SK; Carr SA; Klaholz BP; Myers AG
    Cell Chem Biol; 2018 Dec; 25(12):1506-1518.e13. PubMed ID: 30318461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tetracyclines function as dual-action light-activated antibiotics.
    He Y; Huang YY; Xi L; Gelfand JA; Hamblin MR
    PLoS One; 2018; 13(5):e0196485. PubMed ID: 29742128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Future development of antibiotics. 4. Tetracycline antibiotics].
    Goto S; Nishida M
    Nihon Rinsho; 1984 Mar; 42(3):547-52. PubMed ID: 6433077
    [No Abstract]   [Full Text] [Related]  

  • 11. Aerobic and anaerobic susceptibility tests with three tetracyclines. Reassessment of the "class concept" of disk testing.
    Barry AL; Draper DL; Wong MK
    Am J Clin Pathol; 1978 Nov; 70(5):821-5. PubMed ID: 717289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 16S rRNA mutations that confer tetracycline resistance in Helicobacter pylori decrease drug binding in Escherichia coli ribosomes.
    Nonaka L; Connell SR; Taylor DE
    J Bacteriol; 2005 Jun; 187(11):3708-12. PubMed ID: 15901694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotics that affect the ribosome.
    Lambert T
    Rev Sci Tech; 2012 Apr; 31(1):57-64. PubMed ID: 22849268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tetracycline antibiotics and resistance mechanisms.
    Nguyen F; Starosta AL; Arenz S; Sohmen D; Dönhöfer A; Wilson DN
    Biol Chem; 2014 May; 395(5):559-75. PubMed ID: 24497223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The tetracyclines.
    Cunha BA; Comer JB; Jonas M
    Med Clin North Am; 1982 Jan; 66(1):293-302. PubMed ID: 7038336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic inhibitors of the bacterial ribosome.
    Weisblum B; Davies J
    Bacteriol Rev; 1968 Dec; 32(4 Pt 2):493-528. PubMed ID: 4179192
    [No Abstract]   [Full Text] [Related]  

  • 17. Simulating activity of the bacterial ribosome.
    Trylska J
    Q Rev Biophys; 2009 Nov; 42(4):301-16. PubMed ID: 20450532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-based design of agents targeting the bacterial ribosome.
    Bower J; Drysdale M; Hebdon R; Jordan A; Lentzen G; Matassova N; Murchie A; Powles J; Roughley S
    Bioorg Med Chem Lett; 2003 Aug; 13(15):2455-8. PubMed ID: 12852942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrolide antibiotic interaction and resistance on the bacterial ribosome.
    Poehlsgaard J; Douthwaite S
    Curr Opin Investig Drugs; 2003 Feb; 4(2):140-8. PubMed ID: 12669373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance to the tetracyclines and macrolide-lincosamide-streptogramin group of antibiotics and its genetic linkage - a review.
    Marosevic D; Kaevska M; Jaglic Z
    Ann Agric Environ Med; 2017 Jun; 24(2):338-344. PubMed ID: 28664720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.